The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Zhejiang University
Celon Pharma SA
Massachusetts General Hospital
The Affiliated Hospital of Qingdao University
Wuhan Ammunition Life-tech Co., Ltd
Revolution Medicines, Inc.
Imperial College London
Assistance Publique - Hôpitaux de Paris
TScan Therapeutics, Inc.
Shanghai Fengxian District Central Hospital
SpeciCare
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Quantgene Inc.
Shenzhen Second People's Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Poniard Pharmaceuticals